Left Atrial Appendage Closure (WATCHMAN) Overview
More than 90% of stroke-causing blood clots that come from the heart are formed in the left atrial appendage (LAA). A cutting-edge procedure, Left Atrial Appendage Closure (LAAC) is designed to reduce the risk of stroke in patients with atrial fibrillation (AFib). The WATCHMAN device is a key player in this process, offering a minimally invasive solution to seal off the left atrial appendage, where blood clots often form in individuals with AFib. By preventing clots from entering the bloodstream, LAAC with the WATCHMAN device provides an effective alternative to long-term anticoagulant therapy, which can pose risks of bleeding. This innovative approach not only helps protect patients from stroke but also enhances their quality of life, allowing them to manage their heart condition with greater confidence and peace of mind.